JP2024533459A5 - - Google Patents
Info
- Publication number
- JP2024533459A5 JP2024533459A5 JP2024515871A JP2024515871A JP2024533459A5 JP 2024533459 A5 JP2024533459 A5 JP 2024533459A5 JP 2024515871 A JP2024515871 A JP 2024515871A JP 2024515871 A JP2024515871 A JP 2024515871A JP 2024533459 A5 JP2024533459 A5 JP 2024533459A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- variant
- acid molecule
- parp1
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163243564P | 2021-09-13 | 2021-09-13 | |
| US63/243,564 | 2021-09-13 | ||
| US202163271171P | 2021-10-24 | 2021-10-24 | |
| US63/271,171 | 2021-10-24 | ||
| PCT/US2022/076298 WO2023039580A2 (en) | 2021-09-13 | 2022-09-12 | Methods of treating clonal hematopoiesis of indeterminate potential (chip) with lymphocyte antigen 75 (ly75), cluster of differentiation 164 (cd164), or poly(adp-ribose) polymerase 1 (parp1) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533459A JP2024533459A (ja) | 2024-09-12 |
| JP2024533459A5 true JP2024533459A5 (enExample) | 2025-09-17 |
Family
ID=83598663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515871A Pending JP2024533459A (ja) | 2021-09-13 | 2022-09-12 | リンパ球抗原７５（ｌｙ７５）、表面抗原分類１６４（ｃｄ１６４）、またはポリ（ａｄｐ－リボース）ポリメラーゼ１（ｐａｒｐ１）阻害剤を用いた未確定の潜在能をもつクローン性造血（ｃｈｉｐ）の治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230113866A1 (enExample) |
| EP (1) | EP4401831A2 (enExample) |
| JP (1) | JP2024533459A (enExample) |
| CA (1) | CA3229899A1 (enExample) |
| MX (1) | MX2024003132A (enExample) |
| WO (1) | WO2023039580A2 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060281672A1 (en) * | 2002-12-06 | 2006-12-14 | Hart Derek N J | Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof |
| WO2014011465A2 (en) * | 2012-07-13 | 2014-01-16 | Albert Einstein College Of Medicine Of Yeshiva University | Aptamer-targeted antigen delivery |
| GB201220010D0 (en) * | 2012-11-07 | 2012-12-19 | Oxford Biotherapeutics Ltd | Therapeutic amd diagnostic target |
| WO2017156416A1 (en) * | 2016-03-11 | 2017-09-14 | The Brigham And Women's Hospital, Inc. | Compositions and methods for treating chemotherapy resistant cancer |
| GB201703876D0 (en) * | 2017-03-10 | 2017-04-26 | Berlin-Chemie Ag | Pharmaceutical combinations |
| EP4660324A3 (en) * | 2020-02-24 | 2026-02-18 | The Board of Trustees of the Leland Stanford Junior University | Methods of analyzing cell free nucleic acids and applications thereof |
-
2022
- 2022-09-12 JP JP2024515871A patent/JP2024533459A/ja active Pending
- 2022-09-12 US US17/931,396 patent/US20230113866A1/en active Pending
- 2022-09-12 EP EP22786243.0A patent/EP4401831A2/en active Pending
- 2022-09-12 CA CA3229899A patent/CA3229899A1/en active Pending
- 2022-09-12 MX MX2024003132A patent/MX2024003132A/es unknown
- 2022-09-12 WO PCT/US2022/076298 patent/WO2023039580A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiao et al. | The long noncoding RNA TTTY15, which is located on the Y chromosome, promotes prostate cancer progression by sponging let-7 | |
| CN102177251B (zh) | 恶性神经胶质瘤的异柠檬酸脱氢酶和其他基因的遗传改变 | |
| KR102622309B1 (ko) | 염색체 상호작용의 검출 | |
| Hayashida et al. | Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype | |
| Meng et al. | DCDC2 is associated with reading disability and modulates neuronal development in the brain | |
| AU2011312504B2 (en) | Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease | |
| Lee et al. | Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions | |
| Buysschaert et al. | Genetic evidence for a role of IL33 in nasal polyposis | |
| EP3615694B1 (en) | Il-8, il-6, il-1b and tet2 and dnmt3a in atherosclerosis | |
| WO2007092221A2 (en) | Method for identifying altered vitamin d metabolism | |
| Zhu et al. | Circ-Ddx60 contributes to the antihypertrophic memory of exercise hypertrophic preconditioning | |
| Chang et al. | Association of cyclooxygenase 2 single-nucleotide polymorphisms and hepatocellular carcinoma in Taiwan | |
| Sun et al. | Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake | |
| JP2023504786A (ja) | 抗がん効果増進のためのＥＲＲγ抑制剤を有効成分として含む組成物の用途 | |
| Skalski et al. | Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population | |
| JP5191906B2 (ja) | ヒトの記憶性能に影響を及ぼす遺伝子 | |
| JP2026069683A (ja) | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 | |
| CN114072503A (zh) | 载脂蛋白b拮抗剂 | |
| Lin et al. | Interleukin-37 exacerbates liver inflammation and promotes IFN-γ production in NK cells | |
| Li et al. | Whole transcriptome landscape in HAPE under the stress of environment at high altitudes: new insights into the mechanisms of hypobaric hypoxia tolerance | |
| JP2024533459A5 (enExample) | ||
| Wu et al. | Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway | |
| Zhao et al. | Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor | |
| Zhao et al. | H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR‐141/ICAM‐1 and miR‐139/CXCR4 Axes | |
| Beigi et al. | Investigation of the association between rs4977574 A> G polymorphism in ANRIL gene and coronary artery disease in Iranian population |